Stay updated with breaking news from Base Holding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOLIDEN, Sweden, May 31, 2021 /PRNewswire/ -- The shareholders of SciBase Holding AB (publ), reg.no 556773-4768 (the "Company") are hereby summoned to an extraordinary general meeting on Wednesday
SciBase - Interim report January 1 - March 31, 2021 The first quarter in figures Net sales amounted to TSEK 2,562 (2,469). The loss after tax amounted to TSEK 8,153 (8,936). The loss per share amounted to SEK 0.15 (0.54). The cash flow from current operations was negative in the amount of TSEK 9,473 (7,893). The gross margin reached 52.7% (54.0%). Electrode sales volume increased by 14% and reached 7,496 (6,562) units, a new quarterly high. Repeat sales of electrodes to existing customers increased by 18%. Important events during the quarter Covid-19 continues to affect sales and the ma...
Share this article STOCKHOLM, May 11, 2021 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the launch of the new Non-Melanoma Skin Cancer (NMSC) clinical application following the completion of their MDR certification process. SciBase's strategy is to leverage the Nevisense technology platform to launch additional clinical applications and products. The first clinical application or indication to be added is NMSC, initially for Nevisense 3.0. There are two types of skin cancer: mela...
SciBase receives important European MDR certification STOCKHOLM, May 10, 2021 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that it has been granted certification under the new Medical Device Regulation (MDR). MDR is a set of mandatory legal requirements central for all companies selling medical devices in the EU. The new regulation comes into effect on May 26 th. SciBase is one of very few medical device manufacturers to have completed the MDR certification, after an intensive two ...
SciBase submits first reimbursement application to CMS in Florida -- SciBase Holding AB ("SciBase") (STO:SCIB ), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that an application for Medicare coverage of the Nevisense procedure has been submitted in Florida. In October 2020, SciBase was granted a Category III CPT (CPT III) code from the American Medical Association (AMA) for the Nevisense melanoma detection test. This was the first step in the process to receive reimbursement coverage in the U.S. The application submission for Medicare cove...